| 4LMN | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | ANP, EUI, MG | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers., Hatzivassiliou G, Haling JR, Chen H, Song K, Price S, Heald R, Hewitt JF, Zak M, Peck A, Orr C, Merchant M, Hoeflich KP, Chan J, Luoh SM, Anderson DJ, Ludlam MJ, Wiesmann C, Ultsch M, Friedman LS, Malek S, Belvin M, Nature. 2013 Aug 11. doi: 10.1038/nature12441. PMID:23934108 | ||||||||||||||
| Data retrieval |
![]() |
| View 4LMN in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |